Defective neurite extension is caused by a mutation in amyloid β/A4 (Aβ) protein precursor found in familial Alzheimer's disease

Journal of Neurobiology

Volumn 32, Issue 5, 1997, Pages 469-480

  Li, Hai Ling ^a   Roch, Jean Marc ^a,b   Sundsmo, Mary ^a   Otero, Deborah ^a   Sisodia, Sangram ^c   Thomas, Ronald ^a   Saitoh, Tsunao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ABBOTT LABORATORIES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Familial Alzheimer's Disease; mutation; neurite extension; sAPP

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL PROTECTION; CERCOPITHECIDAE; FAMILIAL DISEASE; GENE MUTATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SEQUENCE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL SIZE; CENTRAL NERVOUS SYSTEM; COS CELLS; CULTURE MEDIA, CONDITIONED; FAMILY HEALTH; HUMANS; MUTAGENESIS; NEURITES; NEURONS; PROTEIN STRUCTURE, TERTIARY; RATS;

EID: 0030951506     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4695(199705)32:5<469::AID-NEU3>3.0.CO;2-3     Document Type: Article

References (30)

1. BEHL, C., DAVIS, J., COLE, G. M., and SCHUBERT, D. (1992). Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186:944-1050.
2. BOTTENSTEIN, J. E., and SATO, G. H. (1979). Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514-517.
3. CAI, X. D., GOLDE, T. E., and YOUNKIN, S. G. (1993). Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259:514-516.
4. CHAO, C., Hu, S., KRAVITZ, F., TSANG, M., ANDERSON, W., and PETERSON, P. (1994). Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol. Chem. Neuropathol. 23:159-178.
5. CHEN, M., and YANKNER, B. (1991). An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci. Lett. 125:223-226.
6. CITRON, M., OLTERSDORF, T., HAASS, C., MCCONLOGUE, L., HUNG, A. Y., SEUBERT, P., VIGO-PELFREY, C., LIEBERBURG, I., and SELKOE, D. J. (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674.
7. GSCHWIND, M., and HUBER, G. (1995). Apoptic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J. Neurochem. 65:292-300.
8. HARRIS, M., HENSLEY, K., BUTTERFIELD, D., LEEDLE, R., and CARNEY, J. (1995). Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hipppocampal neurons. Exp. Neural. 131:193-202.
9. JIN, L.-W., NINOMIYA, H., ROCH, J.-M., SCHUBERT, D., OTERO, D. A. C., and SAITOH, T. (1994). Peptides containing RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14:5461-5470.
10. GHISO, J., ROSTAGNO, A., GARDELLA, J. E., LIEM, L., GOREVIC, P. D., and FRANGIONE, B. (1992). A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. J. Biochem. 288:1053-1059.
11. LAMBERT, M., STEVENS, G., SABO, S., BARBER, K., WANG, G., WADE, W., KRAFT, G., SNYDER, S., HOLZMAN, T., and KLEIN, W. (1994). β/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 39:377-385.
12. Lo, A. C., HAASS, C., WAGNER, S. L., TEPLOW, D. B., and SISODIA, S. S. (1994). Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J. Biol. Chem. 269:30966-30973.
13. MASLIAH, E., and TERRY, R. (1993). The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol. 3:77-85.
14. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:409-414.
15. MULLAN, M., CRAWFORD, F., AXELMAN, K., HOULDEN, H., LILIUS, L., WINBLAD, B., and LANNFELT, I. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1:345-347.
16. NINOMIYA, H., ROCH, J.-M., SUNDSMO, M. P., OTERO, D. A. C., and SAITOH, T. (1993). Amino acid sequence RERMS represents the active domain of amyloid β/ A4 protein precursor that promotes fibroblast growth. J. Cell Biol. 121:879-886.
17. NINOMIYA, H., ROCH, J.-M., JIN, L.-W., and SAITOH, T. (1994). Secreted form of APP binds to two distinct APP binding sites on B103 rat neuronal cells through two different domains, but only one site is involved in trophic activity. J. Neurochem. 63:495-500.
18. PIKE, C. J., CUMMINGS, B. J., and COTMAN, C. W. (1992). β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3:769-772.
19. POLLACK, S., SADLER, I., HAWTIN, S., TAILOR, V., and SHEARMAN, M. (1995). Sulfated glycosaminoglycans and dyes attentuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci. Lett. 184:113-116.
20. SELKOE, D. J. (1994). Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci. 17:489-517.
21. SUZUKI, N., CHEUNG, T. T., CAI, X. D., ODAKA, A., OTVOS, L., Jr., ECKMAN, C., GOLDE, T. E., and YOUNKIN, S. G. (1994). An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (β APP717) mutants. Science 264:1336-1340.
22. TAKASHIMA, A., NOGUCHI, K., SATO, K., HOSHINO, T., and IMAHORI, K. (1993). Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 90:7789-7793.
23. TOMIYAMA, T., ASANO, S., SUWA, Y., MORITA, T., KATAOKA, K., MORI, H., and ENDO, N. (1994). Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204:76-83.
24. 2+ channel blockers attenuate beta-amyloid peptide toxcity to cortical neurons in culture. J. Neurochem. 62:372-375.
25. WHITSON, J. S., MIMS, M. P., STRITTMATTER, W. J., YAMAKI, T., MORRISETT, J. D., and APPEL, S. H. (1994). Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Commun. 199:163-170.
26. YAMAMOTO, K., MIYOSHI, T., YARE, T., KAWASHIMA, K., ARAKI, H., HANADA, K., OTERO, D. A. C., ROCH, J.-M., and SAITOH, T. (1994). The survival of rat cerebral cortical neurons in the presence of trophic APP peptides. J. Neurobiol. 25:585-594.
27. YANKNER, B. A., DUFFY, L. K., and KIRSCHNER, D. A. (1990). Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282.
28. YANKNER, B. A., and MESULAM, M. M. (1991). Beta-Amyloid and the pathogenesis of Alzheimer's disease. N. Engl. J. Med. 325:1849-1857.
29. YOUNKIN, S. G. (1991). Processing of the Alzheimer's disease beta A4 amyloid protein precursor (APP). Brain Pathol. 1:253-262.
30. ZHANG, Z., DRZEWIECKI, G., HOM, J., MAY, P., and HYSLOP, P. (1994). Human cortical neuronal (HCN) cell lines: a model for amyloid beta neurotoxicity. Neurosci. Lett. 177:162-164.